This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2004
Title: Moise Levy: Pioneer in NFkappa B Activation Research
Introduction: Moise Levy, a distinguished inventor based in Houston, TX, has made significant contributions to the field of medical research with his groundbreaking patent focused on the diagnosis and treatment of medical conditions associated with defective NFκB activation, specifically Incontinentia Pigmenti (IP).
Latest Patents: Moise Levy holds one patent for his innovative methods, compositions, and kits aimed at addressing defects in NFκB related diseases such as IP.
Career Highlights: With a keen focus on NFκB Essential Modulator and its role in inflammatory and apoptotic pathways, Moise Levy has paved the way for advancements in the treatment of neurocutaneous genodermatoses. His dedication to this complex field has led to the development of novel approaches for managing conditions like IP.
Collaborations: Throughout his career, Moise Levy has collaborated with esteemed colleagues in the industry, including Sue J Kenwrick and Hayley Woffendin. Together, they have shared insights, conducted research, and worked towards improving healthcare outcomes for those affected by NFκB related diseases.
Conclusion: Moise Levy's work exemplifies a commitment to innovation and excellence in the realm of medical research. His patent stands as a testament to his dedication to advancing the field and improving the lives of individuals impacted by NFκB related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile